Dynamic immune response and its influencing factors in COVID-19 patients with non-alcoholic fatty liver disease: A cohort study

Table 6 Pearson correlation analysis between lymphocyte subsets and their percentages and clinical disease severity in coronavirus disease 2019 patients with non-alcoholic fatty liver disease

Variable	Clinical disease severity
	r	P value
LY (cells/μL)	-0.193	< 0.001
LY%	-0.185	< 0.001
CD3+ (cells/μL)	-0.190	< 0.001
CD3+CD4+ (cells/μL)	-0.167	< 0.001
CD3+CD8+ (cells/μL)	-0.162	< 0.001
CD3+%	-0.029	0.461
CD3+CD4+%	-0.007	0.861
CD3+CD8+%	-0.009	0.822
CD4/CD8	0.013	0.743
CD19+ (cells/μL)	-0.115	0.003
CD56+ (cells/μL)	-0.090	0.02
CD19+%	0.016	0.685
CD56+%	0.046	0.236

LY: Lymphocyte counts.